ArticleBMC medical imaging2025
DBT-based habitat imaging for differentiating benign and malignant breast architectural distortion : a two-center study.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multimodal combined model integrating 2.5D deep learning and habitat radiomics for malignancy discrimination in ≤2 cm BI-RADS 4 breast lesions.Quantitative imaging in medicine and surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThis study aims to explore the predictive value of breast architectural distortion, benign and malignant, based on digital breast tomosynthesis (DBT) habitat imaging combined with various machine learning algorithms.
methodsThis retrospective study included 254 architectural distortion lesions from two medical centers between January 2019 to July 2023. The data from the first center were divided into training and validation sets at a ratio of 7:3; the second center served as an external test set. Breast DBT scans of patients were collected. The lesions were delineated layer by layer using ITK-SNAP software, and radiomics features were extracted based on PyRadiomics. Subsequently, Z-score normalization was applied to standardize the features to ensure similar scales and variances. The Bayesian Information Criterion (BIC) was first used to determine the optimal number of clusters, followed by clustering analysis using the Gaussian Mixture Model (GMM) to generate different tumor sub-regions. Feature extraction was then performed for each independent habitat sub-region to obtain habitat imaging features. For these habitat features, a series of processing steps were carried out: first, all features were standardized; next, dimensionality reduction was performed on the training set using hypothesis testing and Least Absolute Shrinkage and Selection Operator (LASSO) to obtain the optimal feature subset. Finally, various machine learning algorithms were employed to construct different radiomics models, which were validated in the internal validation set and external test set. Model evaluation was conducted using the Receiver Operating Characteristic Curve (ROC) and Confusion Matrix
resultsAfter sample allocation, the training set comprised 112 subjects; the internal validation set included 47 individuals; and the external test set contained 95 people. A total of 2,260 habitat imaging features were extracted. Hypothesis testing and LASSO dimensionality reduction were applied, resulting in 19 optimal features for constructing various machine learning models. Among the compared models, logistic regression performed best, with the Area Under the Curve (AUC) values in the training set, internal validation set, and external test set being 0.868, 0.739, and 0.665, respectively.
conclusionThis study demonstrates that habitat imaging based on DBT shows promising discriminative value in distinguishing benign from malignant breast architectural distortion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.